newsMultiple myeloma treatment receives IND from FDA10 February 2020 | By Victoria Rees (European Pharmaceutical Review)The FDA has granted Investigational New Drug (IND) authorisation to KP1237 for the treatment of multiple myeloma using a patient's own Natural Killer cells.